News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
UPDATE: Merck says switching cell lines would impact safety and quality
The anti-abortion group that blames Merck & Co for the recent US measles outbreak says it would not judge parents who have children vaccinated with MMR II for the good of society.
Remicade will be cheaper in Europe according to Merck & Co., which predicted Government mandated price cuts in some markets.
US government scientists told a House subcommittee on oversight and investigations on Tuesday that the six months production time necessary for flu vaccine manufacturers can create difficulties for health experts selecting the appropriate virus strains...